Asahi Songwon Q1 FY27 Results (NSE: ASAHISONG)
Signal: Margin expansion
The read
The operating inflection is substantial: consolidated EBITDA rose 171.56% YoY and EBITDA margin expanded 925bps to 17.3% after contracting margins in Q1-Q3FY26, with Phthalocyanine volume and realisation gains doing most of the work; however, modest inventory gains and management's warning that Blue margins are above sustainable levels make normalization the key test for the next quarter.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹188.91 Cr | +25.35% | +28.57% |
| EBIT | ₹27.93 Cr | N/A | |
| Net profit | ₹19.03 Cr | +633.26% | |
| EPS | ₹16.32 | N/A | |
| EBIT margin | 17.3% |
P&L walk
Consolidated revenue rose to ₹188.91 Cr, +25.35% YoY and +28.57% QoQ, while EBITDA grew 171.56% YoY to ₹32.60 Cr and margin expanded to 17.3%; PAT rose 633.26% YoY to ₹19.03 Cr, with the operating recovery led by Phthalocyanine and only modest support from other income.
Segments
Phthalocyanine drove the consolidated recovery with ₹138.14 Cr of revenue on gains in both volumes and realisations, while AZO contributed ₹17.02 Cr after lower volumes caused by raw-material inflation and customer deferrals; API contributed ₹34.54 Cr as realisations improved for the first time in a prolonged period while volumes continued to grow.
Key positives
- Consolidated revenue reached ₹188.91 Cr, +25.35% YoY and +28.57% QoQ, reversing the -14.8% and -9.7% YoY declines recorded in Q2FY26 and Q3FY26.
- EBITDA increased 171.56% YoY to ₹32.60 Cr and margin expanded to 17.3% from 7.93% in Q1FY26, marking a second consecutive quarter of margin expansion.
- Phthalocyanine revenue was ₹138.14 Cr, with management attributing growth to both healthy volume gains and higher realisations.
- API revenue was ₹34.54 Cr; management reported the first increase in realisations after a prolonged period of pressure while volumes continued to grow.
- Management stated that strong cash flows enabled deleveraging and that no fresh capex is immediately lined up.
Key concerns
- Management said the current Phthalocyanine margin level of 17.3% is slightly above sustainable longer-term levels, creating a normalization risk for subsequent quarters.
- AZO volumes were lower because steep raw-material cost increases led customers to defer purchases; the recovery depends on input costs stabilising and deferred demand returning.
- Q1FY27 profitability included modest inventory gains in the Blue business, which may not recur at the same magnitude.
Research and educational content only. Not investment advice.